{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:04:50Z","timestamp":1794441890939,"version":"4.9.1"},"reference-count":81,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Anticholinergic medication use is associated with adverse clinical outcomes, especially in older adults. However, few studies have assessed the anticholinergic burden in the Thai geriatric population. Hence, we aimed to evaluate the impact of anticholinergic burden on clinical outcomes in older patients after discharge from the hospital.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A prospective cohort study was conducted between January 1 to December 31, 2023. The prescribed medications were assessed at admission and discharge to determine the anticholinergic cognitive burden (ACB) scores. Participants were classified into three groups according to the ACB score at discharge: none (score 0), moderate (score 1\u20132), and severe (score\u2009\u2265\u20093) anticholinergic burden. The Cox proportional hazard model was used to determine the marker risk of high anticholinergic burden to adverse outcomes.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>This study involved 290 older patients admitted to general internal medicine wards. At discharge, 37.9% (n\u2009=\u2009110) of the patients had a high anticholinergic burden (ACB score\u2009\u2265\u20093), and 50% (n\u2009=\u2009145) had a higher ACB score than at admission. The three most commonly prescribed anticholinergics at discharge were benzodiazepines (20.3%), corticosteroids (20.0%), and antihistamines (15.9%). During the one-year follow-up period, 16.6% (n\u2009=\u200948) of the patients died. The incidence rate of all-cause mortality in hospitalized older patients with an ACB score\u2009\u2265\u20093 was 0.65 cases per 1000-person day during a one-year follow-up period. After adjusting for potential factors, an ACB score of \u2265 3 at discharge was marginally associated with one-year mortality post discharge [hazard ratio: 2.98, 95% confidence interval (0.96\u20139.28)].<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The exposure to high anticholinergic burden (ACB scores\u2009\u2265\u20093) at discharge was slightly associated with an increased risk of one-year mortality post discharge. The cautious use of benzodiazepines may assist to reduce the anticholinergic burden in this vulnerable population.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0332946","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:36:33Z","timestamp":1758303393000},"page":"e0332946","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Anticholinergic burden and clinical outcomes among older adults admitted in a tertiary hospital: a prospective cohort study"],"prefix":"10.1371","volume":"20","author":[{"given":"Pornkamol","family":"Tiranaprakij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahaphume","family":"Srisuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krongtong","family":"Putthipokin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3729-798X","authenticated-orcid":true,"given":"Sirasa","family":"Ruangritchankul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"pone.0332946.ref001","author":"World Health Organization","year":"2015"},{"key":"pone.0332946.ref002","author":"Foundation of Thai Gerontology Research and Development Institute (TGRI)","year":"2021"},{"key":"pone.0332946.ref003","unstructured":"Health Committee, British Geriatrics Society. Written evidence from the British Geriatrics Society (ETWP 26). 2011. http:\/\/www.publications.parliament.uk\/pa\/cm201213\/cmselect\/cmhealth\/6\/6vw03.htm"},{"issue":"1","key":"pone.0332946.ref004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2006.11.535","article-title":"Anticholinergic effects of antihistamine drugs used in the clinic","volume":"119","author":"SC Wolff","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"pone.0332946.ref005","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3389\/fnins.2019.01309","article-title":"Anticholinergic Drugs in Geriatric Psychopharmacology","volume":"13","author":"J L\u00f3pez-\u00c1lvarez","year":"2019","journal-title":"Front Neurosci"},{"key":"pone.0332946.ref006","first-page":"45","article-title":"Anticholinergic and sedative medicines - prescribing considerations for people with dementia","volume":"41","author":"JS Bell","year":"2012","journal-title":"Aust Fam Physician"},{"key":"pone.0332946.ref007","doi-asserted-by":"crossref","first-page":"105636","DOI":"10.1016\/j.archger.2024.105636","article-title":"Prevalence of strong anticholinergic use in residents with and without cognitive impairment and frailty: Analysis from 106 nursing homes in 12 Asia-Pacific and European countries","volume":"128","author":"AJ Cross","year":"2025","journal-title":"Arch Gerontol Geriatr"},{"issue":"3","key":"pone.0332946.ref008","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/17512433.2022.2070474","article-title":"Anticholinergics and falls in older adults","volume":"15","author":"XJ Xu","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"pone.0332946.ref009","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12877-023-03820-6","article-title":"The association between anticholinergic burden and mobility: a systematic review and meta-analyses","volume":"23","author":"GO Phutietsile","year":"2023","journal-title":"BMC Geriatr"},{"issue":"6","key":"pone.0332946.ref010","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamaneurol.2016.0580","article-title":"Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults","volume":"73","author":"SL Risacher","year":"2016","journal-title":"JAMA Neurol"},{"issue":"5","key":"pone.0332946.ref011","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/ggi.13234","article-title":"Anticholinergic burden and 1-year mortality among older patients discharged from acute care hospital","volume":"18","author":"F Lattanzio","year":"2018","journal-title":"Geriatr Gerontol Int"},{"key":"pone.0332946.ref012","volume-title":"Anticholinergic medications","author":"N Ghossein","year":"2023"},{"issue":"11","key":"pone.0332946.ref013","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jamda.2014.08.002","article-title":"Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home","volume":"15","author":"F Landi","year":"2014","journal-title":"J Am Med Dir Assoc"},{"issue":"18","key":"pone.0332946.ref014","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.2217\/cer-2022-0160","article-title":"Healthcare and economic burden of anticholinergic use in adults with overactive bladder: a systematic literature review","volume":"11","author":"C Duperrouzel","year":"2022","journal-title":"J Comp Eff Res"},{"issue":"2","key":"pone.0332946.ref015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171353","article-title":"anticholinergic burden and cognitive function in a large German cohort of hospitalized geriatric patients","volume":"12","author":"B Pfistermeister","year":"2017","journal-title":"PLoS One"},{"key":"pone.0332946.ref016","doi-asserted-by":"crossref","first-page":"20420986211012592","DOI":"10.1177\/20420986211012592","article-title":"Anticholinergic burden in older adult inpatients: patterns from admission to discharge and associations with hospital outcomes","volume":"12","author":"M Herrero-Zazo","year":"2021","journal-title":"Ther Adv Drug Saf"},{"issue":"10","key":"pone.0332946.ref017","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/medicina57101115","article-title":"Anticholinergic burden of geriatric","volume":"57","author":"K Wilczy\u0144ski","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"pone.0332946.ref018","doi-asserted-by":"crossref","first-page":"103885","DOI":"10.1016\/j.archger.2019.05.010","article-title":"A review of published anticholinergic scales and measures and their applicability in database. analyses","volume":"87","author":"G Lozano-Ortega","year":"2020","journal-title":"Arch Gerontol Geriatr"},{"key":"pone.0332946.ref019","article-title":"The 2012 update to the anticholinergic cognitive burden scale","volume":"61","author":"NL Campbell","year":"2013","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"pone.0332946.ref020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.asjsur.2018.10.005","article-title":"Anti-cholinergic burden and patient related clinical outcomes in an emergency general surgical setting","volume":"42","author":"AD Ablett","year":"2019","journal-title":"Asian J Surg"},{"key":"pone.0332946.ref021","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejim.2018.11.004","article-title":"The excess mortality risk associated with anticholinergic burden among older patients discharged from acute care hospital with depressive symptoms","volume":"61","author":"A Corsonello","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"11","key":"pone.0332946.ref022","first-page":"942","article-title":"Anticholinergic","volume":"19","author":"F Lattanzio","year":"2023","journal-title":"Anticholinergic"},{"issue":"5","key":"pone.0332946.ref023","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-091465","article-title":"Prevalence of potentially inappropriate medication among older patients in a primary care unit of a tertiary care hospital in Thailand: a retrospective cross-sectional study","volume":"15","author":"T Ananchaisarp","year":"2025","journal-title":"BMJ Open"},{"issue":"5","key":"pone.0332946.ref024","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00228-021-03269-9","article-title":"Potentially inappropriate medication use and the hospitalization rate among Thai elderly patients: a retrospective cohort study","volume":"78","author":"V Varavithya","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"pone.0332946.ref025","first-page":"160","article-title":"n4Studies: sample size calculation for an epidemiological study on a smart device","volume":"68","author":"C Ngamjarus","year":"2016","journal-title":"Siriraj Med J"},{"key":"pone.0332946.ref026","unstructured":"World Health Organization. Anatomical Therapeutic Chemical (ATC) Classification. Available. https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/atc-classification. Accessed 2024 April 8."},{"issue":"8","key":"pone.0332946.ref027","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/ggi.13330","article-title":"Prevalence, risk factors and adverse outcomes of anticholinergic burden in Patients with advanced chronic conditions at hospital admission","volume":"18","author":"D Sevilla-S\u00e1nchez","year":"2018","journal-title":"Geriatr Gerontol Int"},{"issue":"2","key":"pone.0332946.ref028","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11096-020-01010-7","article-title":"Prevalence of anticholinergic burden and risk factors amongst the older population: analysis of insurance claims data of Korean patients","volume":"42","author":"K Jun","year":"2020","journal-title":"Int J Clin Pharm"},{"issue":"10","key":"pone.0332946.ref029","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00228-015-1919-7","article-title":"Anticholinergic burden in Parkinson\u2019s disease inpatients","volume":"71","author":"U Lertxundi","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"pone.0332946.ref030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.mcna.2014.11.003","article-title":"Geriatric syndromes and geriatric assessment for the generalist","volume":"99","author":"C Carlson","year":"2015","journal-title":"Med Clin North Am"},{"key":"pone.0332946.ref031","first-page":"78","article-title":"Development of a comprehensive approach for the early diagnosis of geriatric syndromes in general practice","volume":"2","author":"N Senn","year":"2015","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"pone.0332946.ref032","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1532-5415.2007.01156.x","article-title":"Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept","volume":"55","author":"SK Inouye","year":"2007","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"pone.0332946.ref033","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ageing\/23.2.97","article-title":"The meaning of activities of daily living in a Thai elderly population: development of a new index","volume":"23","author":"S Jitapunkul","year":"1994","journal-title":"Age Ageing"},{"issue":"4","key":"pone.0332946.ref034","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/ageing\/afy021","article-title":"Diagnostic accuracy of Instrumental Activities of Daily Living for dementia in community-dwelling older adults","volume":"47","author":"H-F Mao","year":"2018","journal-title":"Age Ageing"},{"issue":"2","key":"pone.0332946.ref035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000517822","article-title":"Use of the montreal cognitive assessment Thai version to discriminate amnestic mild cognitive impairment from alzheimer\u2019s disease and healthy controls: machine learning results","volume":"50","author":"S Hemrungrojn","year":"2021","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"pone.0332946.ref036","first-page":"172","article-title":"The validity of Thai version of the Montreal cognitive assessment (MoCA-T)","volume":"3","author":"S Tangwongchai","year":"2009","journal-title":"Dement Neuropsychol"},{"issue":"2","key":"pone.0332946.ref037","first-page":"101","article-title":"The Use of GDS-15 in Detecting MDD: A Comparison between residents in a Thai long-term care home and geriatric outpatients","volume":"5","author":"N Wongpakaran","year":"2013","journal-title":"J Clin Med Res"},{"issue":"1","key":"pone.0332946.ref038","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1479-8301.2011.00383.x","article-title":"Prevalence of major depressive disorders and suicide in long-term care facilities: a report from northern Thailand","volume":"12","author":"N Wongpakaran","year":"2012","journal-title":"Psychogeriatrics"},{"issue":"3","key":"pone.0332946.ref039","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/NT.0000000000000092","article-title":"Body Mass Index: Obesity, BMI, and Health: A Critical Review","volume":"50","author":"FQ Nuttall","year":"2015","journal-title":"Nutr Today"},{"issue":"4","key":"pone.0332946.ref040","first-page":"516","article-title":"Simplified malnutrition tool for Thai patients","volume":"22","author":"S Komindrg","year":"2013","journal-title":"Asia Pac J Clin Nutr"},{"issue":"1","key":"pone.0332946.ref041","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s12877-020-01801-7","article-title":"A scoping review of the Clinical Frailty Scale","volume":"20","author":"S Church","year":"2020","journal-title":"BMC Geriatr"},{"issue":"5","key":"pone.0332946.ref042","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"K Rockwood","year":"2005","journal-title":"CMAJ"},{"issue":"3","key":"pone.0332946.ref043","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","article-title":"Impact of anticholinergics on the aging brain: a review and practical application","volume":"4","author":"M Boustani","year":"2008","journal-title":"Aging Health"},{"issue":"2","key":"pone.0332946.ref044","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ageing\/afu185","article-title":"Total anticholinergic burden and risk of mortality and cardiovascular disease over 10 years in 21,636 middle-aged and older men and women of EPIC-Norfolk prospective population study","volume":"44","author":"PK Myint","year":"2015","journal-title":"Age Ageing"},{"issue":"7624","key":"pone.0332946.ref045","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"E von Elm","year":"2007","journal-title":"BMJ"},{"issue":"1","key":"pone.0332946.ref046","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3810\/hp.2011.02.371","article-title":"Clinical and demographic factors associated with antimuscarinic medication use in older hospitalized patients","volume":"39","author":"E Lowry","year":"2011","journal-title":"Hosp Pract (1995)"},{"issue":"1","key":"pone.0332946.ref047","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12877-023-04640-4","article-title":"Disentangling drug contributions: anticholinergic burden in older adults linked to individual medications: a cross-sectional population-based study","volume":"24","author":"G Bhatkhande","year":"2024","journal-title":"BMC Geriatr"},{"issue":"3","key":"pone.0332946.ref048","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/jgs.14034","article-title":"Anticholinergic Drug Burden in Persons with Dementia Taking a Cholinesterase Inhibitor: The Effect of Multiple Physicians","volume":"64","author":"CE Reppas-Rindlisbacher","year":"2016","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"pone.0332946.ref049","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.archger.2014.01.006","article-title":"The relationship between total anticholinergic burden (ACB) and early in-patient hospital mortality and length of stay in the oldest old aged 90 years and over admitted with an acute illness","volume":"59","author":"AC Kidd","year":"2014","journal-title":"Arch Gerontol Geriatr"},{"issue":"2","key":"pone.0332946.ref050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/11585060-000000000-00000","article-title":"Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients: a prospective study","volume":"28","author":"J Uusvaara","year":"2011","journal-title":"Drugs Aging"},{"issue":"5","key":"pone.0332946.ref051","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2165\/11631420-000000000-00000","article-title":"Drug Burden Index and hospitalization among community-dwelling older people","volume":"29","author":"E L\u00f6nnroos","year":"2012","journal-title":"Drugs Aging"},{"issue":"1","key":"pone.0332946.ref052","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jgs.13206","article-title":"Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people","volume":"63","author":"MS Salahudeen","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"pone.0332946.ref053","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1177\/0091270011421489","article-title":"Drug burden index, physical function, and adverse outcomes in older hospitalized patients","volume":"52","author":"E Lowry","year":"2012","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"pone.0332946.ref054","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s00223-023-01072-5","article-title":"Association of polypharmacy and anticholinergic burden with length of stay in hospital amongst older adults admitted with hip fractures: a retrospective observational study","volume":"112","author":"D Fluck","year":"2023","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"pone.0332946.ref055","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1192\/bjp.bp.115.173971","article-title":"Association of anticholinergic burden with adverse effects in older people with intellectual disabilities: an observational cross-sectional study","volume":"209","author":"M O\u2019Dwyer","year":"2016","journal-title":"Br J Psychiatry"},{"issue":"3","key":"pone.0332946.ref056","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044230","article-title":"Anticholinergic drug burden according to the anticholinergic drug scale and the German anticholinergic burden and their impact on cognitive function in multimorbid elderly German people: a multicentre observational study","volume":"11","author":"C Kr\u00fcger","year":"2021","journal-title":"BMJ Open"},{"issue":"3","key":"pone.0332946.ref057","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40266-018-0522-x","article-title":"Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden","volume":"35","author":"AR Green","year":"2018","journal-title":"Drugs Aging"},{"issue":"9","key":"pone.0332946.ref058","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/BF02239305","article-title":"Effect of anticholinergic agents on the intestinal absorption of 59 Fe ferrous citrate","volume":"16","author":"H Orrego-Matte","year":"1971","journal-title":"Am J Dig Dis"},{"key":"pone.0332946.ref059","first-page":"153","article-title":"Effects of acetylcholine and spermineNONOate on erythrocyte hemorheologic and oxygen carrying properties","volume":"25","author":"R Mesquita","year":"2001","journal-title":"Clin Hemorheol Microcirc"},{"issue":"3","key":"pone.0332946.ref060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00232-010-9250-9","article-title":"Nonneuronal cholinergic system in human erythrocytes: biological role and clinical relevance","volume":"234","author":"JPL de Almeida","year":"2010","journal-title":"J Membr Biol"},{"issue":"511","key":"pone.0332946.ref061","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw3781","article-title":"Muscarinic acetylcholine receptor regulates self-renewal of early erythroid progenitors","volume":"11","author":"G Trivedi","year":"2019","journal-title":"Sci Transl Med"},{"issue":"2","key":"pone.0332946.ref062","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.clpt.6100035","article-title":"Anticholinergic drugs and physical function among frail elderly population","volume":"81","author":"F Landi","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"pone.0332946.ref063","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/ageing\/afaa090","article-title":"Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis","volume":"49","author":"NT Pieper","year":"2020","journal-title":"Age Ageing"},{"issue":"4","key":"pone.0332946.ref064","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12603-016-0787-x","article-title":"Anticholinergic Burden and functional status in older people with cognitive impairment: results from the regal project","volume":"21","author":"V Boccardi","year":"2017","journal-title":"J Nutr Health Aging"},{"issue":"2","key":"pone.0332946.ref065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40266-012-0044-x","article-title":"Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study","volume":"30","author":"L Pasina","year":"2013","journal-title":"Drugs Aging"},{"key":"pone.0332946.ref066","doi-asserted-by":"crossref","first-page":"789986","DOI":"10.3389\/fnut.2022.789986","article-title":"An increased anticholinergic drug burden index score negatively affect nutritional status in older patients without dementia","volume":"9","author":"E Ates Bulut","year":"2022","journal-title":"Front Nutr"},{"issue":"7","key":"pone.0332946.ref067","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s40520-020-01707-9","article-title":"Association between anticholinergic burden and oropharyngeal dysphagia among hospitalized older adults","volume":"33","author":"S Castej\u00f3n-Hern\u00e1ndez","year":"2021","journal-title":"Aging Clin Exp Res"},{"issue":"6","key":"pone.0332946.ref068","doi-asserted-by":"crossref","first-page":"587","DOI":"10.30773\/pi.2019.0275","article-title":"Benzodiazepine-related cognitive impairment or dementia: a signal detection study using a case\/non-case approach","volume":"17","author":"Y-H Baek","year":"2020","journal-title":"Psychiatry Investig"},{"issue":"2","key":"pone.0332946.ref069","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/acps.12909","article-title":"The risk of Alzheimer\u2019s disease associated with benzodiazepines and related drugs: a nested case-control study","volume":"138","author":"V Tapiainen","year":"2018","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"pone.0332946.ref070","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1017\/S104161021700223X","article-title":"Use of benzodiazepines and cognitive performance in primary care patients with first cognitive complaints","volume":"30","author":"G Grande","year":"2018","journal-title":"Int Psychogeriatr"},{"issue":"10","key":"pone.0332946.ref071","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s40618-023-02091-7","article-title":"Glucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations","volume":"46","author":"D De Alcubierre","year":"2023","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"pone.0332946.ref072","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00228-017-2312-5","article-title":"Anticholinergic burden and health outcomes among older adults discharged from hospital: results from the CRIME study","volume":"73","author":"M Guti\u00e9rrez-Valencia","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"pone.0332946.ref073","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1532-5415.2011.03491.x","article-title":"Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study","volume":"59","author":"C Fox","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"pone.0332946.ref074","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.maturitas.2015.10.009","article-title":"Anticholinergic burden is associated with recurrent and injurious falls in older individuals","volume":"84","author":"A Zia","year":"2016","journal-title":"Maturitas"},{"issue":"3","key":"pone.0332946.ref075","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40266-018-00630-z","article-title":"Drugs contributing to anticholinergic burden and risk of fall or fall-related injury among older adults with mild cognitive impairment, dementia and multiple chronic conditions: a retrospective cohort study","volume":"36","author":"AR Green","year":"2019","journal-title":"Drugs Aging"},{"issue":"2","key":"pone.0332946.ref076","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/bcp.12617","article-title":"Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis","volume":"80","author":"K Ruxton","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"pone.0332946.ref077","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/bcp.12839","article-title":"Pharmacological management of anticholinergic delirium - theory, evidence and practice","volume":"81","author":"AH Dawson","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"pone.0332946.ref078","doi-asserted-by":"crossref","first-page":"869","DOI":"10.4088\/JCP.11ac07093","article-title":"Rediscovering adverse anticholinergic effects","volume":"72","author":"P Gerretsen","year":"2011","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"pone.0332946.ref079","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","author":"2023 Geriatrics Society B the","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"pone.0332946.ref080","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3","volume":"14","author":"D O\u2019Mahony","year":"2023","journal-title":"Eur Geriatr Med"},{"issue":"4","key":"pone.0332946.ref081","first-page":"174","article-title":"Evidence-based clinical practice guideline for deprescribing cholinesterase inhibitors and memantine in people with dementia","volume":"210","author":"E Reeve","year":"2018","journal-title":"Recommendations"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0332946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T21:53:55Z","timestamp":1758318835000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0332946"}},"subtitle":[],"editor":[{"given":"Joseph Olusesan","family":"Fadare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":81,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0332946","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0332946.g001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0332946.g002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0332946.t001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0332946.t002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0332946.t003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0332946.t004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0332946.t005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0332946.t006","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0332946.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0332946.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0332946.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0332946.s004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0332946.s005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0332946.s006","asserted-by":"subject"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]}}}